India Preclinical Imaging Market (2024-2029)
The India Preclinical Imaging Market was valued at $15.9 Million in 2024 and projected to reach to $20 Million by 2029, representing a compound annual growth rate of 4.7%. India's preclinical imaging market is poised for steady growth driven by expanding pharmaceutical research capabilities and increasing government support for biomedical research infrastructure.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
India Preclinical Imaging Market Trends and Insights
- India's market growth is driven by increasing investments in research and development infrastructure, rising adoption of advanced imaging technologies in academic and pharmaceutical institutions, and growing demand for non-invasive diagnostic solutions in preclinical research.
- The expansion reflects India's strengthening position as a hub for biomedical research and drug development in the Asia Pacific region. India's preclinical imaging sector benefits from government initiatives supporting scientific research, collaboration between domestic and international research organizations, and the emergence of contract research organizations (CROs) utilizing advanced imaging modalities.
- India's market is characterized by growing awareness of imaging technologies such as micro-CT, ultrasound, and optical imaging among research institutions.
- The forecast period through 2029 indicates sustained momentum as India continues to enhance its research capabilities and attract pharmaceutical and biotechnology investments..
Key Market Statistics
- CAGR (2024-2029) 4.7% CAGR
- Market Size, 2024 ~USD 15.9 Million
- Forecast, 2029 ~USD 20 Million
- Country India
India Preclinical Imaging Market Overview
Market Valuation :
India's preclinical imaging market was valued at USD 15.9 million in 2024 and is projected to reach USD 20.0 million by 2029, representing steady growth in the South Asian region.
R&D Infrastructure Expansion :
Increasing government and private sector investments in research and development infrastructure across Indian pharmaceutical and biotech companies are driving adoption of advanced preclinical imaging technologies.
Academic Institution Growth :
Rising adoption of preclinical imaging systems in Indian academic research centers, medical colleges, and pharmaceutical institutions is accelerating market penetration and technology standardization.
Competitive CAGR Performance :
India's preclinical imaging market is expanding at a CAGR of 4.7% from 2024-2029, slightly below the global average of 5%, indicating emerging market potential with room for acceleration.
India Preclinical Imaging Market Dynamics
- The country's growing focus on drug discovery and development, coupled with rising collaborations between Indian institutions and global research organizations, is creating significant demand for advanced imaging technologies.
- Investment in academic research facilities and the establishment of specialized research centers are expected to further boost market expansion.
- However, cost constraints and limited awareness in smaller research institutions may moderate growth rates compared to developed markets..
Market Ecosystem
Related Ecosystem
Diagnostic Imaging
- Magnetic Resonance Imaging (MRI)
- Computed Tomography (CT)
- CT Scanners
- Nuclear Imaging
- Positron Emission Tomography
- Siemens healthineers
- PHILIPS HEALTHCARE
- CANON INC.
- FUJIFILM Holdings Corporation
- UNITED IMAGING HEALTHCARE CO., LTD.
Medical Devices
- Polymerase Chain Reaction (PCR)
- Magnetic Resonance Imaging (MRI)
- Disposable Autoinjectors
- Pulse Oximeters
- Blood Pressure Monitors
- Medtronic plc
- Abbott Laboratories
- Stryker Corporation
- Becton, Dickinson and Company
- CONMED Corporation
Key Takeaways
- India's preclinical imaging market is valued at USD 15.9 million in 2024 and will reach USD 20.0 million by 2029.
- India's market is expanding at a 4.7% CAGR, driven by increased R&D investments and adoption of advanced imaging technologies.
- India's growing CRO sector and government research initiatives are accelerating demand for preclinical imaging solutions.
- India's position as a biomedical research hub supports sustained market growth through 2029.
Preclinical Imaging Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2024 |
| Fastest Growing Segment | NUCLEAR IMAGING SYSTEMS (Type) |
| Forecast Period | 2024–2029 |
| Growth Rate | CAGR of 5% from 2024 to 2029 |
| Largest Segment | PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES (End User) |
| Market Size Base Year (Billions) | ~USD 4 (2024) |
| Revenue Forecast (Billions) | ~USD 5.1 (2029) |
| Segments Covered | Product, Type, Application, End User |
India Preclinical Imaging Market Report Segmentation
4 segment dimensions are covered across the global market.
By Product
- Imaging Systems
- Reagents
- Software
By Type
- Barium-Based Contrast Agents
- Bioluminescence Imaging Systems
- Fluorescence Imaging Systems
- Gadolinium-Based Contrast Agents
- Gallium-67-Based Spect Probes
- Gastrografin-Based Contrast Agents
- Gold Nanoparticles
- Iodine-131-Based Spect Probes
- Iodine-Based Contrast Agents
- Iron-Based Contrast Agents
- Magnetic Particle Imaging Systems
- Manganese-Based Contrast Agents
- Micro-Ct Systems
- Micro-Mri Systems
- Micro-Ultrasound Systems
- Nuclear Imaging Systems
- Optical Imaging Systems
- Other Optical Imaging Systems
- Other Spect Probes
- Photoacoustic Imaging Systems
- Technetium-99M-Based Spect Probes
- Thallium-201-Based Spect Probes
By Application
- Cardiology
- Immunology & Inflammation
- Infectious Diseases
- Neurology
- Oncology
- Other Applications
By End User
- Academic & Research Centers
- Imaging Centers
- Other End Users
- Pharmaceutical & Biotechnology Companies
INDIA: PRECLINICAL IMAGING MARKET, BY END USER, 2023–2029
| Segment | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|
| ACADEMIC & RESEARCH CENTERS | 24.7 | 26.1 | 27.6 | 29.2 | 30.9 | 32.6 | 34.5 | 5.7 |
| IMAGING CENTERS | 13.9 | 14.8 | 15.7 | 16.6 | 17.6 | 18.7 | 19.8 | 6.1 |
| OTHER END USERS | 6.2 | 6.4 | 6.7 | 7 | 7.3 | 7.6 | 7.9 | 4.3 |
| PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES | 109.8 | 115.7 | 121.9 | 128.5 | 135.4 | 142.7 | 150.3 | 5.4 |
| TOTAL | 154.6 | 163 | 171.9 | 181.3 | 191.2 | 201.6 | 212.6 | 5.4 |
Target Audience
- Pharmaceutical Companies : Indian and multinational pharmaceutical firms need preclinical imaging market data to optimize R&D investments, evaluate technology adoption timelines, and benchmark against industry standards in drug development.
- Biotech Startups : Emerging biotech companies in India require market insights to understand competitive landscape, identify funding opportunities, and make informed decisions about preclinical imaging infrastructure investments.
- Academic Research Institutions : Universities and research centers across India need market intelligence to justify equipment purchases, secure funding for imaging facilities, and align research capabilities with global standards.
- Medical Device Manufacturers : Preclinical imaging equipment vendors and manufacturers need India-specific market data to develop localized sales strategies, identify distribution partners, and forecast demand across research institutions.
- Government & Policy Bodies : Indian government agencies and policy makers require market analysis to inform R&D funding decisions, establish research infrastructure priorities, and support the country's biomedical innovation ecosystem.
Key Companies in the India Preclinical Imaging Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| PATHEON INC | Netherlands | Private Company | Optical Imaging (Bioluminescance),PET,SPECT, |
| ANALOGIC CORPORATION | United States | Private Company | MRI,PET,SPECT, |
| XILINX, INC. | United States | Private Company | Optical Imaging (Bioluminescance),PET,SPECT, |
| GUERBET GROUP | France | InvalidIdentifier | PET,SPECT,MRI, |
| BRUKER CORPORATION | United States | Public Company | MRI,PET,SPECT, |
| REVVITY, INC. | United States | Public Company | Optical Imaging (Bioluminescance),PET,SPECT, |
| OPTISCAN IMAGING LTD. | Australia | Public Company | Optical Imaging (Bioluminescance),PET,SPECT, |
PATHEON INC
Patheon Inc. is a Netherlands-based private company with 9,100 employees operating in the pharmaceutical and life sciences sector.
ANALOGIC CORPORATION
Analogic Corporation is a United States-based private company founded in 1967 with 1,510 employees, specializing in medical and aerospace technology solutions.
XILINX, INC.
Xilinx, Inc. is a United States-based private company founded in 1984 with 4,890 employees, operating in the semiconductor and programmable logic industry.
GUERBET GROUP
Guerbet Group is a France-based company in the medical imaging and pharmaceutical sector.
BRUKER CORPORATION
Bruker Corporation is a United States-based public company founded in 1960 with 11,085 employees, providing scientific instruments and analytical solutions.
REVVITY, INC.
Revvity, Inc. is a United States-based public company founded in 1937 with 11,000 employees, operating in the life sciences and diagnostics industry.
OPTISCAN IMAGING LTD.
Optiscan Imaging Ltd. is an Australia-based public company founded in 1994 with 9 employees, specializing in optical imaging technology.
Reasons to Buy this Report
- Market Entry Strategy : Gain comprehensive insights into India's preclinical imaging landscape to develop targeted market entry strategies and identify high-potential customer segments within pharmaceutical and academic institutions.
- Investment Decision Support : Access detailed market sizing, growth projections, and CAGR analysis specific to India to support investment decisions and resource allocation in the South Asian preclinical imaging sector.
- Competitive Positioning : Understand India-specific market dynamics, key growth drivers, and emerging opportunities to position your products and services competitively against local and international competitors.
- Customer Identification : Identify and prioritize target customer segments including pharmaceutical companies, biotech firms, academic research centers, and government institutions actively investing in preclinical imaging technologies.
- Growth Opportunity Assessment : Evaluate the 4.7% CAGR trajectory and USD 4.1 million market expansion opportunity from 2024-2029 to assess long-term revenue potential and business development priorities in India.
Frequently asked questions
What is the current size of India's preclinical imaging market?
India's preclinical imaging market was valued at USD 15.9 million in 2024.
What is the projected market size for India's preclinical imaging sector by 2029?
India's preclinical imaging market is projected to reach USD 20.0 million by 2029.
What is the CAGR for India's preclinical imaging market?
India's preclinical imaging market is growing at a compound annual growth rate of 4.7% from 2024 to 2029.
What factors are driving growth in India's preclinical imaging market?
India's market growth is driven by increased R&D investments, rising adoption of advanced imaging technologies in research institutions, government support for scientific research, and the expansion of contract research organizations.
Which imaging technologies are most relevant to India's preclinical market?
India's preclinical imaging sector utilizes micro-CT, ultrasound, optical imaging, and other non-invasive diagnostic modalities in research institutions and pharmaceutical organizations.
RESEARCH METHODOLOGY
This market research study utilized extensive secondary sources, directories, and databases to identify and collect information relevant to this technical, market-oriented, and financial analysis of the preclinical imaging market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to gather and verify critical qualitative and quantitative information, as well as to assess market prospects. The size of the preclinical imaging market was estimated through various secondary research approaches and triangulated with inputs from primary research to arrive at the final market size.
Secondary Research
The secondary research process involved the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, and SEC filings of companies. Secondary research was employed to identify and collect information relevant to the comprehensive, technical, market-oriented, and commercial study of the preclinical imaging market. It was also used to obtain important information about key players, market classification, and segmentation according to industry trends, as well as key developments related to market and technology perspectives, down to the most detailed level. A database of the key industry leaders was also prepared using secondary research.
Primary Research
Extensive primary research was conducted after acquiring a basic understanding of the global preclinical imaging market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand side (hospital personnel, department heads, hospital directors, corporate personnel) and supply side (such as C-level and D-level executives, technology experts, software developers, marketing and sales managers, among others) across five major regions: North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.
Breakdown of Primary Interviews
Note: Tiers are defined based on the total revenues of companies. As of 2024, Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = < USD 500 million.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the global preclinical imaging market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
- Key players in the global preclinical imaging market were identified through secondary research, and their global market shares were determined through primary and secondary research.
- The research methodology included the study of the annual and quarterly financial reports and regulatory filings, data books of major market players, and interviews with industry experts for detailed market insights.
- All percentage shares, splits, and breakdowns for the global preclinical imaging market were determined by using secondary sources and verified through primary sources.
- All key macroindicators affecting the revenue growth of market segments and subsegments have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get validated and verified quantitative and qualitative data.
- The gathered market data was consolidated and added with detailed inputs and analysis and presented in this report.
Global Preclinical Imaging Market: Bottom-up and Top-down Approach
Data Triangulation
After arriving at the overall market size, from the market size estimation process explained above, the preclinical imaging market was split into segments and subsegments. To complete the overall market engineering process and to arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the preclinical imaging market.
Market Definition
Preclinical imaging involves the application of molecular imaging for the assessment of anatomical, physiological, and functional parameters in live animal models during preclinical studies. Preclinical imaging systems and reagents are utilized to visualize living animals in order to assess the safety and efficacy of novel drug procedures or other medical treatments for human applications. During preclinical studies, a variety of different imaging modalities are utilized, such as optical imaging systems, nuclear imaging systems (micro-PET and micro-SPECT), micro-MRI, micro-ultrasound systems, and micro-CT imaging systems.
Stakeholders
- Preclinical Imaging Instrument Manufacturers, Suppliers, and Imaging Software Providers
- Pharmaceutical and Biotechnology Companies
- Preclinical Imaging Reagent Manufacturers and Suppliers
- Contract Research Organizations (CROs)
- Research and Development (R&D) Companies
- Government Research Laboratories
- Independent Research Laboratories
- Government and Independent Regulatory Authorities
- Medical Research Laboratories
- Academic Medical Institutes and Universities
- Market Research and Consulting Service Providers
Report Objectives
- To define, describe, and forecast the preclinical imaging market by product type, application, end user, and region
- To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
- To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
-
To analyze the opportunities in the market for stakeholders and provide details of
the competitive landscape for preclinical imaging market leaders - To profile the key players in the market and comprehensively analyze their market shares and core competencies
-
To forecast the size of the market segments with respect to five main regions:
North America, the Asia Pacific, Europe, Latin America, and the Middle East & Africa - To track and analyze competitive developments, such as partnerships, acquisitions, product launches & approvals, and expansions
- To benchmark players within the preclinical imaging market using the Competitive Evaluation Matrix, which analyzes market players on various parameters within the broad categories of business strategy, market share, and product offering
Get the Full Preclinical Imaging Market Report
Full forecast, segment splits, and company analysis for all Preclinical Imaging Market.
- US Preclinical Imaging Market
- Canada Preclinical Imaging Market
- Germany Preclinical Imaging Market
- UK Preclinical Imaging Market
- France Preclinical Imaging Market
- Italy Preclinical Imaging Market
- Spain Preclinical Imaging Market
- Japan Preclinical Imaging Market
- China Preclinical Imaging Market
- Brazil Preclinical Imaging Market
- Mexico Preclinical Imaging Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
